New Drug Innovation And Production Program To Focus On Ten Diseases
This article was originally published in PharmAsia News
Executive Summary
At the 2009 International Conference for Bioeconomy in Tianjin, Sang Guowei, chief technology director for China's new drug innovation and production program, talked about progress in the program. Three objectives have been set: (1) developing new drugs with effectiveness, safety and low price; (2) cultivating specialized talent in the Yangtze River Delta, Pearl River Delta and Bohai Bay Rim to set up a healthcare system which conforms to China's conditions; and (3) speeding up TCM modernization. To meet the healthcare reform requirements, especially to align with those of rural medical cooperatives, the project will allocate 43 percent of its total research funds to fight 10 major diseases, including malignant tumors, cerebral and cardiac vascular diseases, diabetes, mental disorders, immunological diseases, AIDS, drug-resistant tuberculosis, drug-resistant tumors and viral diseases. (Click here for more - Chinese Language)
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.